TNFAIP3 and systemic sclerosis: Using SSc patient-derived skin and lung tissues and isolated fibroblasts combined with experiments in engineered mice harboring germline or fibroblast-specific deletion of A20 or DREAM, we now demonstrate that A20 expression was reduced in SSc, while expression of DREAM, the negative regulator of A20, was significantly elevated and anti-correlated with A20.